Novartis Investigative Site

Kristianstad 291 85

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Hypertension

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension — Completed